周围动脉疾病和急性冠状动脉综合征后静脉血栓事件:脂蛋白的作用和alirocumab的修饰:ODYSSEY结果随机临床试验的预定分析
在PubMed上查看摘要
概括
此摘要是机器生成的。在急性冠状动脉综合征患者,特别是高脂蛋白患者中,alirocumab的PCSK9抑制减少了外周动脉疾病 (PAD) 的发生. 需要进一步的研究来证实PCSK9抑制可以降低静脉瘤风险.
科学领域
- 心血管医学
- 药理学
- 临床试验
背景情况
- 患有急性冠状动脉综合征 (ACS) 的患者面临周围动脉疾病 (PAD) 和静脉血栓塞栓症 (VTE) 的风险.
- 抑制剂有效降低脂肪蛋白和LDL-C.
- 这项研究研究了PCSK9抑制对ACS后PAD和VTE事件的影响.
研究的目的
- 为了确定PCSK9抑制是否减少PAD事件和VTE在ACS患者.
- 探索这些减少与脂蛋白和LDL-C水平之间的关系.
主要方法
- 一个预先规定的ODYSSEY OUTCOMES随机临床试验分析,涉及18924名ACS患者.
- 患者接受了PCSK9抑制剂阿利罗库马布或安慰剂,同时接受了他类药物治疗.
- 评估了PAD事件 (关键肢体缺血,再血管,截肢) 和静脉瘤 (DVT,PE),并对LDL- C进行了脂蛋白 () 校正.
主要成果
- 阿利罗库马布显著减少了PAD事件 (HR,0. 69;P=0. 004) 并显示了减少静脉瘤的趋势 (HR,0. 67;P=0. 06).
- PAD事件的减少与基线脂蛋白水平有关,而不是LDL- C.
- 与静脉突发症风险相关的脂蛋白变化 (但不是LDL- C)
结论
- 在接受他类药物治疗的ACS患者中,阿里古马布可减少PAD事件,特别是在高脂蛋白患者中.
- 需要进一步的研究来证实阿里古马布对静脉瘤风险的影响及其与脂蛋白的关系.
- 这项以NCT01663402注册的研究提供了关于PCSK9抑制对心血管结果的关键见解.
相关概念视频
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

